FactMR today released its latest report on the Organ Preservation Solutions Market, providing comprehensive insights into the global market’s significant growth driven by the rising demand for organ transplants, increasing prevalence of organ failure, and advancements in preservation technologies. Valued at USD 286.8 million in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 7.2%, reaching USD 574.7 million by 2035. This expansion highlights the critical role of organ preservation solutions in bridging the gap between organ availability and successful transplantation outcomes.

Download Free Sample Copy of Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7752

Market Outlook and Growth Projections

The global organ preservation solutions market is poised for substantial growth from 2025 to 2035, driven by the increasing number of organ transplant procedures and the rising burden of chronic diseases leading to organ failure. Organ preservation solutions, such as University of Wisconsin (UW), Custodiol HTK, and Perfadex, are essential for maintaining organ viability during storage and transportation. The report projects the market to grow from USD 286.8 million in 2025 to USD 574.7 million by 2035, with a consistent CAGR of 7.2%. This growth is fueled by technological advancements in preservation techniques, growing organ donation networks, and increasing healthcare investments, creating significant opportunities for stakeholders.

Key Drivers Fueling Market Demand

The organ preservation solutions market is propelled by several key factors. The rising prevalence of chronic diseases, such as kidney failure, liver cirrhosis, and heart disease, is driving demand for organ transplants, with over 120,000 patients on U.S. transplant waiting lists in 2022. The increasing geriatric population, projected to reach 2 billion by 2050, further escalates the need for transplants due to age-related organ failures. Technological advancements, such as normothermic machine perfusion (NMP), which maintains organs in near-physiological conditions, are enhancing transplant success rates and expanding the donor pool. Government initiatives, like India’s National Organ Transplant Programme, and awareness campaigns are boosting organ donation rates, particularly in Asia-Pacific, where China’s market is expected to grow at a CAGR of 9%. Additionally, innovations like bioengineered solutions and oxygenated perfusion are improving organ viability, further driving market growth.

Challenges and Restraints in the Sector

Despite its promising outlook, the market faces significant challenges. A critical shortage of organ donors, with only 49 deceased donors per million population in Spain in 2019, limits transplant availability. High costs of transplant procedures and preservation technologies, often ranging from USD 100,000 to over USD 1 million, restrict access, particularly in developing regions. Ethical concerns, such as informed consent and potential exploitation in organ procurement, as highlighted in recent posts on X, pose additional barriers. The report also notes logistical challenges, including procurement delays and limited cryogenic infrastructure in regions like Asia-Pacific and the Middle East, which contribute to organ wastage. Providers must address these issues through cost-effective solutions, regulatory harmonization, and enhanced infrastructure to ensure broader accessibility.

Segment-Wise Insights and Dominant Trends

The report provides detailed segmentation analysis, identifying static cold storage (SCS) as the dominant technique, holding a 45% market share in 2024 due to its simplicity, cost-effectiveness, and wide applicability for organs like kidneys and livers. Normothermic machine perfusion (NMP) is the fastest-growing segment, with a projected CAGR of 7.2%, driven by its ability to reduce ischemia-reperfusion injury and assess organ viability. By organ type, kidneys lead with a 35% share, followed by livers and lungs, with lung preservation growing rapidly due to Perfadex’s effectiveness. Hospitals and organ transplant centers dominate end-user segments, while organ banks are gaining traction. Key trends include the adoption of AI for organ quality assessment, portable oxygenated perfusion devices, and personalized preservation solutions tailored to specific organs, enhancing transplant outcomes.

Regional Outlook and Growth Hotspots

North America holds the largest market share, with a 46% share in 2024, driven by advanced healthcare infrastructure, high transplant volumes (42,887 in the U.S. in 2022), and FDA approvals for innovative systems like TransMedics’ OCS Heart System. Europe follows, with Spain leading due to its robust organ donation program. The Asia-Pacific region is expected to exhibit the fastest growth, with a projected CAGR of 9%, fueled by rising healthcare investments, an aging population, and increasing organ donation awareness in China and India. Latin America and the Middle East and Africa (MEA) are emerging markets, with Brazil performing over 12,000 transplants in 2021 and initiatives like Mexico’s ALIANZA boosting donation rates. The report identifies Asia-Pacific as a key growth engine due to its expanding transplant infrastructure and supportive regulations.

Recent Developments

The market has seen significant advancements in 2024 and early 2025. In November 2023, Paragonix Technologies launched a comprehensive donor organ procurement and preservation network across the U.S., enhancing logistics and transplant coordination. In April 2022, TransMedics received FDA approval for its OCS Heart System, enabling ex vivo preservation of donor hearts. Recent posts on X highlight ethical concerns and innovations, such as stem cell-based organ repair, indicating a shift toward alternative solutions. Companies like XVIVO Perfusion collaborated with Contatti Medical in 2021 to expand transplant services in Brazil. The adoption of fuel cell technology for sustainable power in preservation systems is also gaining traction, supporting market growth.

Key Players Insights

Leading players are driving innovation through strategic partnerships and product advancements. Waters Medical Systems leads with its kidney preservation solutions, while XVIVO Perfusion excels in lung preservation with Perfadex. TransMedics dominates with its Organ Care System, and OrganOx focuses on liver preservation. Other key players, including Paragonix Technologies, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST Century Medicine, Shanghai Genext Pharmaceutical Technology, and Bridge to Life, are investing in NMP and bioengineered solutions. Recent developments include Paragonix’s milestone of preserving over 2,000 donor organs in August 2022. These companies are pursuing R&D, acquisitions, and regional expansion to meet growing transplant demands, with strong growth projected through 2035.

Competitive Landscape

The market features a moderately fragmented competitive ecosystem with key players driving innovation and market share. Companies profiled include Waters Medical Systems, XVIVO Perfusion, TransMedics, OrganOx, Paragonix Technologies, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, 21ST Century Medicine, Shanghai Genext Pharmaceutical Technology, and Bridge to Life. These firms lead in developing advanced preservation solutions and perfusion technologies. The report includes a detailed competition dashboard, benchmarking, and market share analysis, highlighting strategies such as product innovation, strategic collaborations, and expansion into emerging markets. As the market evolves, these players are well-positioned to capitalize on opportunities in advanced preservation techniques and global transplant demand.

Strategic Recommendations and Future Implications

FactMR’s report offers actionable recommendations, urging stakeholders to invest in NMP and AI-driven organ assessment technologies to improve transplant outcomes. Providers should focus on cost-effective solutions and expand cryogenic infrastructure in emerging markets like Asia-Pacific. The study includes value chain analysis, PESTLE factors, and SWOT assessments to support strategic decision-making. As organ transplant demand rises and technologies advance, organ preservation solutions will remain pivotal in saving lives and addressing the global organ shortage.

FactMR delivers comprehensive market reports and valuable business insights, uncovering trends, growth paths, and competitive landscapes. Committed to accuracy and reliability, FactMR empowers businesses with critical data and strategic recommendations, enhancing market positioning. With a global presence and experienced analysts, FactMR ensures reliable market intelligence, equipping clients to capitalize on opportunities.

For more information, visit https://www.factmr.com/report/organ-preservation-solutions-market